Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $129.76 | 2 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| DePuy Synthes Sales Inc. | $116.77 | 1 | $0 (2019) |
| Genentech USA, Inc. | $12.99 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $12.99 | 1 | Genentech USA, Inc. ($12.99) |
| 2019 | $116.77 | 1 | DePuy Synthes Sales Inc. ($116.77) |
All Payment Transactions
2 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: Virology & Specialty Care | ||||||
| 11/27/2019 | DePuy Synthes Sales Inc. | EMBOTRAP II Revascularization Device (Device) | Food and Beverage | In-kind items and services | $116.77 | General |
| Category: Neurovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 755 | 779 | $149,277 | $37,334 |
| 2022 | 14 | 512 | 573 | $102,622 | $31,625 |
| 2021 | 8 | 628 | 648 | $155,048 | $38,691 |
| 2020 | 8 | 321 | 327 | $87,806 | $19,294 |
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 213 | 216 | $69,552 | $13,604 | 19.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 110 | 110 | $35,970 | $8,683 | 24.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 51 | 51 | $16,677 | $4,873 | 29.2% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 80 | 81 | $8,343 | $3,285 | 39.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $6,403 | $2,258 | 35.3% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 85 | 88 | $2,898 | $1,430 | 49.3% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 12 | 12 | $1,812 | $603.36 | 33.3% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 19 | 30 | $1,350 | $486.60 | 36.0% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2023 | 23 | 24 | $1,300 | $475.80 | 36.6% |
| 73610 | X-ray of ankle, minimum of 3 views | Office | 2023 | 20 | 21 | $1,113 | $414.54 | 37.2% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 23 | 23 | $989.00 | $359.46 | 36.3% |
| 73110 | X-ray of wrist, minimum of 3 views | Office | 2023 | 11 | 12 | $720.00 | $261.04 | 36.3% |
| 73130 | X-ray of hand, minimum of 3 views | Office | 2023 | 15 | 17 | $340.00 | $238.00 | 70.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 14 | $700.00 | $134.04 | 19.1% |
| 71045 | X-ray of chest, 1 view | Office | 2023 | 11 | 12 | $179.00 | $120.92 | 67.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 49 | 49 | $931.00 | $107.80 | 11.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 140 | 156 | $42,632 | $10,508 | 24.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 45 | 69 | $13,477 | $6,794 | 50.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 54 | 54 | $15,591 | $4,051 | 26.0% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 71 | 71 | $10,721 | $3,628 | 33.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 29 | 29 | $7,719 | $2,883 | 37.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 21 | 24 | $6,167 | $1,161 | 18.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 12 | 12 | $1,380 | $822.48 | 59.6% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 34 | 38 | $1,303 | $623.86 | 47.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 12 | 12 | $468.00 | $347.76 | 74.3% |
About Dr. Kurt Jaeger, M.D
Dr. Kurt Jaeger, M.D is a Emergency Medical Technician, Basic healthcare provider based in Festus, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1578501011.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kurt Jaeger, M.D has received a total of $129.76 in payments from pharmaceutical and medical device companies, with $12.99 received in 2021. These payments were reported across 2 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($129.76).
As a Medicare-enrolled provider, Jaeger has provided services to 2,216 Medicare beneficiaries, totaling 2,327 services with total Medicare billing of $126,942. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Practice Information
- Specialty Emergency Medical Technician, Basic
- Other Specialties Basic|Family Medicine
- Location Festus, MO
- Active Since 06/04/2006
- Last Updated 12/09/2014
- Taxonomy Code 146N00000X
- Entity Type Individual
- NPI Number 1578501011
Products in Payments
- EMBOTRAP II Revascularization Device (Device) $116.77
- Xofluza (Drug) $12.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.